Cheyenne Regional Medical Center Now Offers Advanced Tests Supporting Diagnosis of Allergy and Autoimmune Diseases
August 1, 2024 – New blood tests provided by Thermo Fisher Scientific yield swift and precise results to aid clinicians in crafting tailored treatment strategies for patients. Cheyenne Regional Medical Center (CRMC) is excited to announce the addition of advanced tests from Thermo Fisher Scientific to its array of services, aimed at bolstering the diagnosis of allergy and autoimmune diseases for patients.
The newly introduced blood tests encompass the ImmunoCAP™ Specific IgE whole allergen tests and ImmunoCAP™ Specific IgE allergen component tests for environmental and food allergies. Additionally, CRMC now offers EliA™ tests to assist in diagnosing autoimmune conditions like lupus, rheumatoid arthritis and celiac disease.
ImmunoCAP™ Specific IgE blood tests stand out as the most extensively utilized specific IgE blood test, with a robust backing evidenced in over 6,000 peer-reviewed publications. These tests play a crucial role in pinpointing allergic sensitivities to prevalent environmental allergens — be it seasonal or perennial, indoor or outdoor — alongside common food allergens such as peanuts, eggs and milk.
Moreover, the ImmunoCAP™ Specific IgE allergen component tests contribute significantly to identifying allergies to bee, wasp, dog, cat and horse, while also uncovering potentially life-threatening reactions to red meat triggered by tick bites. The outcomes from these cutting-edge allergy diagnostic tests empower specialists and healthcare providers to distinguish genuine allergic sensitivities from cross-reactivity, evaluate the risk of systemic reactions like anaphylaxis, recognize allergic triggers that may induce asthma exacerbations, minimize false positives, and inform future therapy decisions.
EliA™ tests furnish clinically pertinent and precise insights to guide healthcare practitioners in making well-informed treatment choices. This test lineup aids in diagnosing prevalent systemic and organ-specific autoimmune disorders, spanning connective tissue diseases, rheumatoid arthritis, antiphospholipid syndrome, vasculitis, Goodpasture syndrome, celiac disease, autoimmune liver ailments and autoimmune thyroid disorders.
Laboratory Director, Rissa Lease shared, “The CRMC Laboratory is constantly evaluating how to decrease turnaround times, decrease the time to physician intervention, and increase the quality of care we’re providing. Bringing allergy and autoimmune testing in-house will accomplish all three tasks in the form of a simple blood test.”
The introduction of these advanced diagnostic tests marks a significant stride in enhancing the diagnostic capabilities at Cheyenne Regional Medical Center. By offering patients access to state-of-the-art testing solutions, CRMC reaffirms its commitment to delivering exceptional healthcare services tailored to individual needs.
